Provided by Tiger Trade Technology Pte. Ltd.

uniQure NV

23.46
+0.09000.39%
Post-market: 23.43-0.0310-0.13%19:40 EDT
Volume:1.95M
Turnover:45.46M
Market Cap:1.63B
PE:-5.81
High:23.72
Open:23.72
Low:22.71
Close:23.37
52wk High:71.50
52wk Low:8.73
Shares:69.37M
Float Shares:57.53M
Volume Ratio:0.22
T/O Rate:3.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0399
EPS(LYR):-3.4602
ROE:-157.61%
ROA:-15.72%
PB:5.02
PE(LYR):-6.78

Loading ...

uniQure announces plan for BLA submission for AMT-130

TIPRANKS
·
Jun 17

uniQure says FDA accepts Phase I/II data as basis for AMT-130 accelerated approval BLA

Reuters
·
Jun 17

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:00 AM

Reuters
·
Jun 17

Don't Ignore The Insider Selling In uniQure

Simply Wall St.
·
Jun 15

uniQure director Robert Gut disposes of USD 280,751 in common shares

Reuters
·
Jun 13

uniQure director Jack Kaye disposes of USD 79,367.45 in ordinary shares

Reuters
·
Jun 06

A Look At uniQure (QURE) Valuation After Strong Recent Share Price Gains

Simply Wall St.
·
Jun 02

A Look At uniQure (QURE) Valuation After AMT-130 Gene Therapy Regulatory Plans And Trial Update

Simply Wall St.
·
May 25

Biotech Investors Are Tuning Out the MAHA Chaos -- Heard on the Street -- WSJ

Dow Jones
·
May 20

Makary exit may temporarily lift biotech sentiment but FDA leadership vacuum looms

Reuters
·
May 14

BUZZ-U.S. STOCKS ON THE MOVE-Nebius, US chipmakers, Assertio Holdings

Reuters
·
May 13

uniQure CMO Walid Abi-Saab sells USD 1.13 million in shares

Reuters
·
May 13

Stock Track | uniQure NV Soars 6.87% Intraday as FDA Commissioner Announces Resignation

Stock Track
·
May 13

BUZZ-U.S. STOCKS ON THE MOVE-Tyler Technologies, Autodesk, Illumina

Reuters
·
May 13

BUZZ-Replimune, uniQure rise; FDA commissioner Makary plans to resign

Reuters
·
May 13

uniQure price target lowered to $50 from $70 at H.C. Wainwright

TIPRANKS
·
May 07

uniQure Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 07

Goldman Sachs Sticks to Its Hold Rating for uniQure (QURE)

TIPRANKS
·
May 06

Chardan Capital Remains a Buy on uniQure (QURE)

TIPRANKS
·
May 06

Analysts’ Top Healthcare Picks: Spyre Therapeutics (SYRE), uniQure (QURE)

TIPRANKS
·
May 06